Home Oncimmune

Oncimmune

acquired
Post-IPO Round
Early Cancer Detection Technology Developer
Basic
Enterprise Profile

Basic Information

Oncimmune is the industry leader in early cancer detection. The company is committed to advancing early cancer detection through its proprietary autoantibody testing technology. The company's mission is to develop early cancer detection tests capable of identifying over 90% of solid tumor cancers.
Oncimmune
Nottingham,England,United Kingdom
101~500 people
January 01, 2006
clientservices@oncimmune.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design
Technology
Molecular Diagnostics Biotechnology
Concept
Lung Cancer
Application Scenarios
Early Disease Screening